Canopy Growth Corporation has grown revenue −2.5% a year over three years and −13% a year over five. Revenue growth, 3-year annual rate: −2.5% (Drug Manufacturers - Specialty & Generic median +13%). Revenue growth, 5-year rate: −13%, growth has picked up over the last three years. Years of annual history on file: 9, FY2018 to FY2026, as filed.

CGCCanopy Growth Corporation

Healthcare

$0.85-42% 1Y

$0.85

$0.8552 weeks$1.92

Latest close: a new 52-week lowOct 8, 2026what changed →

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin narrowing (−14.5 points).

1 to watch, 1 neutral, 1 without data

Revenue trend+7% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −12% a year.

Margin direction−14.5 points operating

Trailing-twelve-month operating margin, -55.6% now against -41.1% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CGC growing?

Canopy Growth Corporation has grown revenue −2.5% a year over three years and −13% a year over five.

−2.5%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · shrinking · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: −13%
Revenue growth, 5-year rate · −2.5% over three · growth has picked up over the last three years
Years of annual history on file: 9
Years of annual history on file · FY2018 to FY2026, as filed

Details›